Estrogen and the postmenopausal breast. Mammographic considerations

Area of Science:

• Radiology
• Oncology
• Endocrinology

Background:

• Hormone replacement therapy (HRT) is commonly used for menopausal symptom management.
• Estrogen therapy can induce mammographic changes, potentially mimicking or obscuring breast pathology.

Observation:

• Mammographic findings such as cystic or dysplastic changes have been observed in patients undergoing postmenopausal estrogen replacement therapy.
• These radiological alterations may regress following the cessation of hormone therapy.

Findings:

• Discontinuation of estrogen replacement therapy can lead to the radiological regression of hormone-induced dysplastic breast changes.
• This cessation may enhance the reliability of both radiologic and clinical breast evaluations.

Implications:

• Temporarily discontinuing hormone therapy in select patients may facilitate clearer breast imaging interpretation.
• Reversal of therapy-induced changes can improve the detection and characterization of underlying malignant neoplasms.
• This approach aids in differentiating benign hormonal effects from true neoplastic disease, optimizing patient management.